Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHSE:603896) commences share repurchases on October 13, 2020, under the program mandated by the shareholders in the Extraordinary General Meeting held on October 13, 2020. As per the mandate, the company is authorized to repurchase up to 3,600,000 shares for a maximum amount of CNY 216 million. The shares will be repurchased at price not more than CNY 60 per share. All shares to be repurchased will be used to implement equity incentives. The program will be valid for twelve months from the date of approval.